SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2025ACC: 0001415889-25-022801
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-9.37K
Net shares
Net seller
$125.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.37K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−9.37K
Price / share
$13.39
Trade value
$125.44K
% of position
2.6%
8/20/2025
364.79K→355.42K
Total
Net shares
−9.37K
Net value
-$125.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2025 | F · Tax Withholding | −9.37K | $13.39 | $125.44K | 2.6% | 364.79K | 355.42K |
| Total | −9.37K | -$125.44K | ||||||
Derivative Transactions0
No derivative transactions reported